London, May 1, 2025 – Aktiia, the blood pressure intelligence platform, has closed an oversubscribed $42 million Series B round co-led by Earlybird Health and Wellington Partners, with new backing from Kfund and naturalX Health Ventures and support from its existing investors. Total funding now tops $100 million.
Alongside the funding, Aktiia is rebranding to Hilo. The new name reflects its goal to make cuffless, clinically validated blood pressure checks easy and available to everyone. Hilo has already sold over 120,000 devices, earned CE marking, gained approvals in Canada, Australia and Saudi Arabia, and posted 76% annual revenue growth.
Read the full press release (PDF):
Download here
